1Azoulay D, Castaing D. Smail A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Sirg, 2000. 231 : 480 - 486.
2Storm FK. Hyperthemia in cancer therpy[M] , Boston : Hall Medical Publishers, 1993:585 - 593.
3Gilly Fn, et al. Reprtitive high - dose topotecan,carboplatin,and paclitaxel phase I study. Int Surg ,1991 ; 76(3) : 164 - 167.
4Ikeba K, Okubo M, Takeda S, et al , Five-year results of cyclic semihigh dose neoadjuvant chemotherapy supported by autologous peripheral blood stem - cell transplantation in patients with advanced ovarian cancer. Int J Clin Oncol, 2004,9(2) :113-119.
5Dorigo O, Berek JS. Gene therapy for ovarian cancer: development of novel treatment strategies. Int J Gyneeol Cancer, 1997, 7 1-13.
6Deisseroth AB, Kavanagh J, Champlin R. Use of safety - modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic ceils. A pilot trial. Hum Gene Ther, 1994; 5: 1507 - 1522.
7Santoso JT, Tang DC, Lane SB. et al. Adenovirus-based p53 gene therapy in ovarian cancer. Gynecol Oncol, 1995 ;59 : 171 - 178.
8Watson JM. Berek JS. Martinez-Maza O. Growth inhibition of ovarian cancer ceils induced by antisense IL-6 oligonucleotides. Gynecol Oncol,1993;49:8.
